Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 817 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated Advanced KRAS p.G12D-mutated NSCLC and PADC EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers MOST POPULAR Colorectal Cancer Screening: The Silver Lining September 1, 2020 FDA Approves Lurbinectedin in Combination with Atezolizumab or Atezolizumab and Hyaluronidase-tqjs... October 16, 2025 EMA Recommends Granting a Marketing Authorisation for Zanubrutinib for the Treatment... October 21, 2021 CCDI Activities Enhance NCI’s Childhood and AYA Cancer Research July 13, 2020 Load more HOT NEWS FDA Grants Accelerated Approval to Zanidatamab-hrii for Patients with Previously Treated... Study Confirms Dinutuximab Extends Life for Children with High-Risk Neuroblastoma New Immunotherapy Option Approved for Cervical Cancer, Rare Lymphoma France Bans all Textured and Polyurethane Breast Implants Amid BIA-ALCL Cancer...
